Regenerative medicine — the idea of generating new cells to replace damaged body tissues and organs — hasn’t gone mainstream yet. But miPS Labs says it’s never too early to start planning for what could be the next big wave in the treatment of disease. The Seattle startup is about to launch a closed beta that will let people freeze a sample of their cells now, so they’re ready to go whenever scientists figure out how to use those cells to grow human tissues, like a new heart. Alex Jiao, miPS co-founder and University of Washington bioengineering PhD candidate, says the whole… Read More
GeekWireGeekWire
 
Representing the interests of inventors in the negotiations with the US Patent Office. Consulting on the use of copyright. Patent service in the USA.
Registration of copyright and patent services in the United States. Registration of agreements on transfer of intellectual property rights